Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
The Korean Journal of Gastroenterology
>
2021
>
77
Volume:
77
1. Efficacy of Adjuvant Chemotherapy after Neoadjuvant FOLFIRINOX and Following Resection of Pancreatic Cancer
Page:95-96—
2. Fish Bone of Branchiostegus Japonicas Causing Actinomycosis in the Cecum in Male on Jeju Island
Page:92—94
3. Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals
Page:88—91
4. Cap-assisted Endoscopic Mucosal Resection of Rectal Perineurioma Mimicking a Neuroendocrine Tumor
Page:84—87
5. Endoscopic Management of Dysphagia
Page:77—83
6. Pharmacological Treatments of Esophageal Dysphagia
Page:71—76
7. Diagnosis of Dysphagia: High Resolution Manometry & EndoFLIP
Page:64—70
8. Approach of Dysphagia
Page:57—63
9. Usefulness of Deep Learning in Analyzing of Microsatellite Instability in Colorectal Tumors
Page:54—55
10. Gastric Volvulus
Page:50—53
11. Primary Pancreatic Candidiasis Mimicking Pancreatic Cancer in an Immunocompetent Patient
Page:45—49
12. Fasciola Hepatica Induced Hepatic Abscess Treated with Triclabendazole
Page:39—44
13. Hepatic Hydatid Cyst: A Case Report
Page:35—38
14. Case of Crohn’s Disease Initially Misdiagnosed as Intestinal Tuberculosis Due to Active Pulmonary Tuberculosis
Page:30—34
15. Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B
Page:22—29
16. Therapeutic Potential of Escherichia coli Nissle 1917 in Clinically Remission-attained Ulcerative Colitis Patients: A Hospital-based Cohort Study
Page:12—21
17. Current Status of Deceased Donor Liver Transplantation for Alcoholic Liver Disease in Korea in MELD Era
Page:4—11
18. Therapeutic Approach to Inflammatory Bowel Disease Using Human Microbial Modification
Page:1—3
19. Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era
Page:145—147
20. Xanthogranulomatous Cholecystitis Suspected as Metastatic Gallbladder Cancer
Page:141—144
21. Endoscopic Band Ligation in Endoscopic Retrograde Cholangiopancreatography Related Duodenal Perforation
Page:136—140
22. Primary Aortoduodenal Fistula Causes Massive Melena: A Case Report
Page:132—135
23. Atorvastatin Induces FXR and CYP7A1 Activation as a Result of the Sequential Action of PPARγ/PGC-1α/HNF-4α in Hep3B Cells
Page:123—131
24. Effectiveness of Albumin-bilirubin Score as a Predictor of Post-hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
Page:115—122
25. How to Study the Sex and Gender Effect in Biomedical Research?
Page:104—114
26. Large Animal Models in Pancreas and Biliary Disease
Page:99—103
27. Prediction of Posthepatectomy Liver Failure by Liver Function Test: Beyond Child Classification
Page:97—98
28. Utilization of Long-term Ambulatory Reflux Monitoring as a Guide for Future Treatment in Gastroesophageal Reflux Disease with Inappropriate Response to Proton Pump Inhibitors
Page:202—203
29. Acute Ischemic Gastropathy with Portal Venous Gas
Page:199—201
30. Ruptured Pancreaticoduodenal Artery Aneurysm with Pancreatitis Treated Using Endovascular and Endoscopic Methods
Page:194—198
31. Successful Medical Treatment for Peritonitis Resulting from a Large Pyogenic Liver Abscess Rupture
Page:190—193
32. Multicenter, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of a Controlled-release, Once-daily UIC201609/UIC201610 Combination Therapy for Functional Dyspepsia: Preliminary Study
Page:171—178
33. Endoscopic Treatment for Superficial Nonampullary Duodenal Tumors
Page:164—170
34. How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease
Page:160—163
35. Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
Page:156—159
36. How to Cope with COVID-19 in the Endoscopy Room
Page:151—155
37. The Effect of Proton Pump Inhibitor and Prokinetics Combination Therapy for Functional Dyspepsia
Page:149—150
38. Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid Combination in Chronic Hepatitis Related to Metabolic Syndrome Components
Page:179—189
39. When is the Optimal Timing of a Rescue Technique for Selective Biliary Cannulation During Endoscopic Retrograde Cholagiopancreatography?
Page:321—323
40. Colonic Granular Cell Tumors
Page:317—320
41. Acute Colonic Pseudo-obstruction Induced by Neuroleptic Malignant Syndrome
Page:313—316
42. Russell Body Lesions of the Colon: Case Report and Literature Review
Page:309—312
43. Colonic Mass Secondary to Sevelamer-associated Rectal Ulcer
Page:305—308
44. Eosinophilic Colitis that Presented with Subepithelial Tumor-like Lesions
Page:300—304
45. Small Bowel Necrosis Associated with Catastrophic Antiphospholipid Syndrome: A Case Report
Page:294—299
46. Changes in the Hepatitis B Surface Antigen Level According to the HBeAg Status and Drug Used in Long-term Nucleos(t)ide Analog-treated Chronic Hepatitis B Patients
Page:285—293
47. Centrally Mediated Abdominal Pain Syndrome
Page:277—284
48. Research Ethics in the Process of Conducting Research
Page:267—276
49. Principles and Fallacies in Medical Appraisal: Focusing on Gastroenterology Cases
Page:263—266
50. MPV17-related Hepatocerebral Mitochondrial DNA Depletion Syndrome
Page:248—252
51. The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability-high Metastatic Colorectal Cancer
Page:261—262
52. Symptomatic Esophageal Leiomyoma
Page:258—260
53. Cannulation of the Portal Vein during Endoscopic Retrograde Cholangiopancreatography in a Patient with Choledocholithiasis
Page:253—257
54. How Should We Do Different Approach to Treat Inflammatory Bowel Disease by Gender Difference?
Page:241—247
55. Treatment of Inflammatory Bowel Disease in Elderly Patients – What Are Different and What Should We Know?
Page:231—240
56. How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?
Page:227—230
57. Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?
Page:220—226
58. Suggestions for the Development of Education Guideline for Abdominal US Education Specialists
Page:217—219
59. The Role of Training Institutions and Academic Societies for the Training and Education of GI Fellows
Page:214—216
60. Impact of COVID-19 on Gastroenterology Fellowship Training
Page:205—213
61. Utilization of Long-term Ambulatory Reflux Monitoring as a Guide for Future Treatment in Gastroesophageal Reflux Disease with Inappropriate Response to Proton Pump Inhibitors
Page:202—203
62. Acute Ischemic Gastropathy with Portal Venous Gas
Page:199—201
63. Ruptured Pancreaticoduodenal Artery Aneurysm with Pancreatitis Treated Using Endovascular and Endoscopic Methods
Page:194—198
64. Successful Medical Treatment for Peritonitis Resulting from a Large Pyogenic Liver Abscess Rupture
Page:190—193
65. Multicenter, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of a Controlled-release, Once-daily UIC201609/UIC201610 Combination Therapy for Functional Dyspepsia: Preliminary Study
Page:171—178
66. Endoscopic Treatment for Superficial Nonampullary Duodenal Tumors
Page:164—170
67. How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease
Page:160—163
68. Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
Page:156—159
69. How to Cope with COVID-19 in the Endoscopy Room
Page:151—155
70. The Effect of Proton Pump Inhibitor and Prokinetics Combination Therapy for Functional Dyspepsia
Page:149—150
71. Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid Combination in Chronic Hepatitis Related to Metabolic Syndrome Components
Page:179—189
72. When is the Optimal Timing of a Rescue Technique for Selective Biliary Cannulation During Endoscopic Retrograde Cholagiopancreatography?
Page:321—323
73. Colonic Granular Cell Tumors
Page:317—320
74. Acute Colonic Pseudo-obstruction Induced by Neuroleptic Malignant Syndrome
Page:313—316
75. Russell Body Lesions of the Colon: Case Report and Literature Review
Page:309—312
76. Colonic Mass Secondary to Sevelamer-associated Rectal Ulcer
Page:305—308
77. Eosinophilic Colitis that Presented with Subepithelial Tumor-like Lesions
Page:300—304
78. Small Bowel Necrosis Associated with Catastrophic Antiphospholipid Syndrome: A Case Report
Page:294—299
79. Changes in the Hepatitis B Surface Antigen Level According to the HBeAg Status and Drug Used in Long-term Nucleos(t)ide Analog-treated Chronic Hepatitis B Patients
Page:285—293
80. Centrally Mediated Abdominal Pain Syndrome
Page:277—284
81. Research Ethics in the Process of Conducting Research
Page:267—276
82. Principles and Fallacies in Medical Appraisal: Focusing on Gastroenterology Cases
Page:263—266
83. MPV17-related Hepatocerebral Mitochondrial DNA Depletion Syndrome
Page:248—252
84. The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability-high Metastatic Colorectal Cancer
Page:261—262
85. Symptomatic Esophageal Leiomyoma
Page:258—260
86. Cannulation of the Portal Vein during Endoscopic Retrograde Cholangiopancreatography in a Patient with Choledocholithiasis
Page:253—257
87. How Should We Do Different Approach to Treat Inflammatory Bowel Disease by Gender Difference?
Page:241—247
88. Treatment of Inflammatory Bowel Disease in Elderly Patients – What Are Different and What Should We Know?
Page:231—240
89. How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?
Page:227—230
90. Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?
Page:220—226
91. Suggestions for the Development of Education Guideline for Abdominal US Education Specialists
Page:217—219
92. The Role of Training Institutions and Academic Societies for the Training and Education of GI Fellows
Page:214—216
93. Impact of COVID-19 on Gastroenterology Fellowship Training
Page:205—213